Lexeo Therapeutics Statistics
NASDAQ: LXEOHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.31+0.01 (+0.30%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Lexeo Therapeutics by the numbers
Lexeo Therapeutics has a market capitalization of $271.7 million based on 82.09M shares outstanding. With trailing EPS of $-1.02, Lexeo Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 24.3% below its 50-day average and 43.1% below its 200-day average.
Average daily trading volume is 1.17M shares, or about $3.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
LXEO valuation vs. peer median
| Metric | LXEO | Peer median | Difference |
|---|---|---|---|
| Market cap | $271.71M | $259.98M | +5% |
| Avg. volume | 1.17M | 754.68K | +55% |
Peer median across 8 companies: IKT, XFOR, SABS, PALI, FATE, SRZN, STRO, LCTX.
Valuation
- Market cap
- $271.71M
- EPS (TTM)
- $-1.02
- Shares outstanding
- 82.09M
Price and trading
- Previous close
- 3.30
- Open
- 3.27
- Day range
- 3.22 – 3.46
- 52-week range
- 2.98 – 10.99
- 52-week change
- -60.31%
- Beta
- —
- Volume
- 1.20M
- Average volume
- 1.17M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 271.71M
- Forward Pe
- -2.43
- Eps
- -1.02
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.99
- Week52 Low
- 2.98
- Avg Volume
- 1.17M
- Shares Outstanding
- 82.09M
- Ma50
- 4.37
- Ma200
- 5.82
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -69.88%
- Pct From52w Low
- 11.07%